Telemetry Investments, L.L.C.

Add to watchlist

$84.4 Million is the total value of Telemetry Investments, L.L.C.'s 177 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 100.0% .

All

			Value		Shares		↓ Weighting
OCAWS	Exit	OMNICHANNEL ACQUISITION CORP*w exp 12/30/202	$0	–	-73,863	-100.0%	-0.02%	–
ANACWS	Exit	ARCTOS NORTHSTAR ACQUIS CORP*w exp 99/99/999	$0	–	-39,964	-100.0%	-0.02%	–
	Exit	ARTISAN ACQUISITION CORP*w exp 05/18/202	$0	–	-54,029	-100.0%	-0.02%	–
ATSPW	Exit	ARCHIMEDES TECH SPAC PARTNR*w exp 04/10/202	$0	–	-47,786	-100.0%	-0.05%	–
TCACW	Exit	TUATARA CAPITAL ACQUISITN CO*w exp 02/11/202	$0	–	-153,301	-100.0%	-0.06%	–
ZSAN	Exit	ZOSANO PHARMA CORP	$0	–	-210,000	-100.0%	-0.07%	–
	Exit	AIRSPAN NETWORKS HOLDINGS IN	$0	–	-20,929	-100.0%	-0.10%	–
CKPT	Exit	CHECKPOINT THERAPEUTICS INC	$0	–	-45,000	-100.0%	-0.13%	–
ESPR	Exit	ESPERION THERAPEUTICS INC NE	$0	–	-17,500	-100.0%	-0.13%	–
	Exit	BABYLON HLDGS LTD*w exp 10/21/202	$0	–	-183,240	-100.0%	-0.16%	–
	Exit	MONEYLION INCcl a	$0	–	-40,000	-100.0%	-0.16%	–
	Exit	MARKETWISE INC	$0	–	-26,500	-100.0%	-0.20%	–
TALK	Exit	TALKSPACE INC	$0	–	-85,000	-100.0%	-0.23%	–
SNDX	Exit	SYNDAX PHARMACEUTICALS INC	$0	–	-10,000	-100.0%	-0.28%	–
MU	Exit	MICRON TECHNOLOGY INC	$0	–	-2,602	-100.0%	-0.32%	–
OCDX	Exit	ORTHO CLINICAL DIAGNOSTICS H	$0	–	-11,000	-100.0%	-0.32%	–
SNAP	Exit	SNAP INCcl a	$0	–	-5,925	-100.0%	-0.34%	–
CRHC	Exit	COHN ROBBINS HOLDINGS CORP	$0	–	-22,288	-100.0%	-0.35%	–
DISCA	Exit	DISCOVERY INC	$0	–	-9,000	-100.0%	-0.35%	–
TECK	Exit	TECK RESOURCES LTDcl b	$0	–	-6,500	-100.0%	-0.42%	–
ITA	Exit	ISHARES TRus aer def etf	$0	–	-3,000	-100.0%	-0.52%	–
SCYX	Exit	SCYNEXIS INC	$0	–	-97,000	-100.0%	-0.60%	–
BPMP	Exit	BP MIDSTREAM PARTNERS LPunit ltd ptnr	$0	–	-26,324	-100.0%	-0.70%	–
	Exit	FOUNDER SPAC	$0	–	-50,000	-100.0%	-0.79%	–
EPAY	Exit	BOTTOMLINE TECH DEL INC	$0	–	-11,822	-100.0%	-1.06%	–
BABA	Exit	ALIBABA GROUP HLDG LTDsponsored ads	$0	–	-6,840	-100.0%	-1.17%	–
VRAY	Exit	VIEWRAY INCcall	$0	–	-220,000	-100.0%	-1.36%	–
CERN	Exit	CERNER CORP	$0	–	-13,964	-100.0%	-2.06%	–
PBCT	Exit	PEOPLES UNITED FINANCIAL INC	$0	–	-74,500	-100.0%	-2.35%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2022-08-15

Signatures

The EDGAR filing(s) were signed by:

Andrew Schorr — CEO

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
RIGEL PHARMACEUTICALS INC	33	Q4 2022	1.7%
AFFIMED N V	31	Q4 2022	3.9%
GLOBALSTAR INC	30	Q4 2022	2.5%
VIEWRAY INC	23	Q4 2022	2.1%
SPDR GOLD TRUST	22	Q4 2022	2.3%
ADMA BIOLOGICS INC	21	Q4 2022	2.9%
STEMLINE THERAPEUTICS INC	21	Q1 2020	1.2%
SPDR S&P 500 ETF TR	20	Q4 2022	53.9%
KADMON HLDGS INC	19	Q2 2021	7.0%
EIGER BIOPHARMACEUTICALS INC	19	Q4 2022	6.7%

View Telemetry Investments, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)

Telemetry Investments, L.L.C. Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Xtant Medical Holdings, Inc.	February 13, 2020	752,915	5.7%
Orexigen Therapeutics, Inc.	February 14, 2019	1,295,844	6.4%
Xtant Medical Holdings, Inc.	February 14, 2018	1,416,339	7.2%

View Telemetry Investments, L.L.C.'s complete significant-ownership history.

Latest filings

Type	Filed
13F-HR	2023-02-14
13F-HR	2022-11-17
13F-HR	2022-08-15
13F-HR	2022-05-16
13F-HR	2022-02-14
13F-HR	2021-11-15
13F-HR	2021-08-16
13F-HR	2021-05-17
13F-HR	2021-02-16
13F-HR	2020-11-16

View Telemetry Investments, L.L.C.'s complete filings history.

All filings

View complete filings history.

Compare quarters

Export Telemetry Investments, L.L.C.'s holdings